AKTS

AKTS is in a Stage 4 decline following a decisive support failure, reinforcing medium-term bearish bias while the long-term uptrend remains intact above the 200 DMA. Short-term conditions are oversold and no clear bounce is visible, suggesting timing favors waiting for a rally into the broken support-turned-resistance near the 9/20 EMAs and 50 SMA (~24.90–25.10) before trimming exposure.

• ↑Cash, cash equivalents, and marketable securities of $517.3M fund ops through 2029.
• ↑Q2 2026 revenue rose 113% YoY to $3.4M, reflecting pipeline traction.
• ↓Q2 net loss jumped to $24.1M from $18.1M year-ago, driven by R&D spend.